Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

720 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dupilumab improves asthma outcomes irrespective of frequency of previous asthma exacerbation history.
Corren J, Castro M, Ford LB, Bernstein JA, Jayawardena S, Maroni J, Rowe P, Amin N, Pirozzi G, Graham NMH, Khan A, Eckert L, Teper A. Corren J, et al. Among authors: bernstein ja. Ann Allergy Asthma Immunol. 2019 Aug;123(2):222-224.e1. doi: 10.1016/j.anai.2019.04.028. Epub 2019 May 8. Ann Allergy Asthma Immunol. 2019. PMID: 31075309 Free article. No abstract available.
Cyclical hypersensitivity, anaphylaxis, and related hormonal reaction.
Lavery WJ, Bernstein JA. Lavery WJ, et al. Among authors: bernstein ja. Ann Allergy Asthma Immunol. 2019 Feb;122(2):140-147. doi: 10.1016/j.anai.2018.11.016. Epub 2018 Nov 22. Ann Allergy Asthma Immunol. 2019. PMID: 30468931 Review. No abstract available.
GINA updated 2019: Landmark changes recommended for asthma management.
Hogan AD, Bernstein JA. Hogan AD, et al. Among authors: bernstein ja. Ann Allergy Asthma Immunol. 2020 Apr;124(4):311-313. doi: 10.1016/j.anai.2019.11.005. Epub 2019 Nov 14. Ann Allergy Asthma Immunol. 2020. PMID: 31734328 No abstract available.
Effect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma and corticosteroid sparing in patients with oral corticosteroid-dependent asthma: results from two phase 3, randomised, double-blind, placebo-controlled trials.
Bernstein JA, Virchow JC, Murphy K, Maspero JF, Jacobs J, Adir Y, Humbert M, Castro M, Marsteller DA, McElhattan J, Hickey L, Garin M, Vanlandingham R, Brusselle G. Bernstein JA, et al. Lancet Respir Med. 2020 May;8(5):461-474. doi: 10.1016/S2213-2600(19)30372-8. Epub 2020 Feb 14. Lancet Respir Med. 2020. PMID: 32066536 Clinical Trial.
720 results